Profile
APYX ABT BSX-PA SYK BSX MDT
Company Name Apyx Medical Corporation Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $57.22M $204.28B $175.45B $148.86B $147.84B $112.64B
Employees 0.25K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Mr. Charles D. Goodwin II Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
APYX ABT BSX-PA SYK BSX MDT
Quant Rating Score 2 3 3 3 3
Quant Rating Sell Neutral Neutral Neutral Neutral
Trading
APYX ABT BSX-PA SYK BSX MDT
Last Close $1.52 $117.78 $122.18 $390.49 $100.31 $87.84
High 52 $2.71 $120.98 $122.18 $395.85 $100.91 $92.27
Low 52 $1.01 $100.07 $122.18 $307.75 $59.92 $76.84
Price vs. 52 Week High -43.91 % -2.65 % 0 % -1.35 % -0.59 % -4.8 %
Price vs. 52 Week Low 50.5 % 17.7 % 0 % 26.89 % 67.41 % 14.32 %
Total Return
APYX ABT BSX-PA SYK BSX MDT
1 Month Return -8.43 % 3.04 % 0 % 6.55 % 11.63 % 7.91 %
3 Month Return 36.94 % 0.66 % 0 % 7.5 % 14.71 % -4.8 %
6 Month Return 4.11 % 13.34 % 0 % 14.27 % 27.64 % 10.63 %
9 Month Return 15.15 % 9.47 % 0 % 16.6 % 45.4 % 8.06 %
YTD Return -3.8 % 4.13 % 0 % 8.45 % 12.3 % 9.96 %
1 Year Return -31.84 % 3.32 % 0 % 25.08 % 65.47 % 1.74 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APYX ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.9 % - 0.83 % - 3.18 %
Dividend Paid and Capex Coverage Ration (TTM) -27.31 % 1.45 % 2.95 % 2.09 % 2.95 % 1.35 %
Dividend Per Share (TTM) - 2.24 % - 3.24 % - 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 33.4 % 1.29 % 84.54 %
Growth
APYX ABT BSX-PA SYK BSX MDT
Asset Growth 53.05 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth 15.89 % -9.7 % 14.01 % 13.12 % 14.01 % 3.12 %
Revenue Growth 17.61 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year 86.67 % 18.5 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year 200.71 % 32.8 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year 11.74 % 63.89 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth 26.75 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Net Income Growth 19.61 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share -55.31 % 30.18 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share -128.02 % 144.68 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share -117.8 % 98.34 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth 26.75 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Operating Cash Flow Growth (CFG) 74.12 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG 67.72 % -6.04 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG 76.05 % 16.69 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG -4.53 % 95.01 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth 19.4 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth 19.4 % -16.37 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share -28.98 % 6.36 % 9.41 % 11.49 % 9.41 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -58.59 % 20.39 % 22.66 % 40.57 % 22.66 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -70.84 % 28.04 % 110.05 % 56.21 % 110.05 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -36.78 % 36.91 % 172.19 % 104.97 % 172.19 % 94.93 %
Dividend Per Share Growth - 8.64 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 42.02 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 82.38 % - 59.67 % - 38.05 %
Dividend 10 Year Growth Per Share - 259.93 % - 183.29 % - 147.94 %
Debt Growth 4736.81 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth 72.84 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
APYX ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 37.43 % 54.7 % 67.3 % 62.47 % 67.3 % 62.65 %
Return on Assets TTM -46.84 % 7.76 % 4.7 % 8.19 % 4.7 % 4.76 %
Return on Equity TTM -156.4 % 14.74 % 8.91 % 18.49 % 8.91 % 8.64 %
Return on Capital Employed TTM -42.16 % 11.6 % 8.57 % 12.38 % 8.57 % 7.56 %
Net Income Per EBT TTM 100.59 % 85.08 % 81.24 % 85.68 % 81.24 % 83.18 %
EBT Per Ebit TTM 131.06 % 98.29 % 79.87 % 93.61 % 79.87 % 87.63 %
EBIT Per Revenue TTM -40.83 % 16.73 % 17.33 % 20.37 % 17.33 % 17.83 %
Cash Flow To Debt Ratio TTM -40.08 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Receivables Turnover TTM 4.05 4.48 6.36 5.88 6.36 5.27
Payables Turnover TTM 17.27 4.63 5.74 6.17 5.74 5.19
Inventory Turnover TTM 3.67 2.74 1.89 1.56 1.89 2.25
Fixed Asset Turnover TTM 779.54 % 388.07 % 454.83 % 557.01 % 454.83 % 512.52 %
Asset Turnover TTM 87.02 % 55.43 % 41.78 % 50.13 % 41.78 % 36.65 %
Operating Cash Flow Per Share TTM -0.45 5.03 1.99 10.07 1.99 5.61
Free Cash Flow Per Share TTM -0.47 3.74 1.33 8.41 1.33 4.29
Cash Per Share TTM 80.86 % 449.02 % 169.89 % 1229.07 % 169.89 % 622.97 %
Operating Cash Flow Sales Ratio TTM -29.46 % 21.18 % 18.45 % 17.47 % 18.45 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.66 % 74.31 % 66.93 % 83.49 % 66.93 % 76.43 %
Cash Flow Coverage Ratios TTM -40.08 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Price To Free Cash Flows Ratio TTM -3.55 31.5 75.88 46.45 75.24 20.48
Price To Operating Cash Flows Ratio TTM -3.38 23.41 50.75 38.76 50.32 15.66
Price Cash Flow Ratio TTM -3.38 23.41 50.75 38.76 50.32 15.66
Income Statement (TTM)
APYX ABT BSX-PA SYK BSX MDT
Revenue $0.05B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $0.03B $22.13B $9.9B $13.1B $9.9B $21.15B
Gross Profit Ratio 64.49% 55.18% 69.49% 63.89% 69.49% 65.34%
EBITDA $-0.02B $10.61B $3.45B $4.93B $3.45B $8.2B
Net Income $-0.02B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -0.54 3.27 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
APYX ABT BSX-PA SYK BSX MDT
Long Term Debt $0.04B $14.55B $8.96B $11.26B $8.96B $24.77B
Total Liabilities $0.05B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $0.03B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0.04B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0.08B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
APYX ABT BSX-PA SYK BSX MDT
Net Income $-0.02B $5.72B $1.59B $3.17B $1.59B $3.68B
Inventory $0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0.01B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 123.22
AEMD Aethlon Medical, Inc. 0.6533
AFIB Acutus Medical, Inc. 0.0695
AHCO AdaptHealth Corp. 10.26
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 235.07
ALUR Allurion Technologies Inc. 3.28
AMIX Autonomix Medical, Inc. Common Stock 2.98
ANIK Anika Therapeutics, Inc. 16.32
AORT Artivion, Inc. 30.605
APEN Apollo Endosurgery, Inc. 10
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.66
AVNS Avanos Medical, Inc. 15.79
AXDX Accelerate Diagnostics, Inc. 1.15
AXGN AxoGen, Inc. 18.68
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 1.0902
ETFs With Exposure to APYX
Unlock